16 October, 2020 - SARS-CoV-2 Webinar

An Update on SARS-CoV-2
Friday, October 16, 2020
14:00-16:00 CEST

The first IABS webinar (May 27th) provided insight into what was known at that point in time about SARS-CoV-2:
the epidemiology worldwide; the disease from an immunology viewpoint and the development of vaccines against the virus.

This 3^rd International Alliance for Biological Standardization COVID-19 webinar brought together a broad range of
international stakeholders, including academia, regulators, funders and industry, with a considerable delegation
from low- and middle-income countries, to provide an update on
the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2,
six months after the previous webinar.

 Although SARS-CoV-2 shows limited evolution, which is beneficial for vaccine development,
recombination of SARS-CoV-2 with another CoV has led to enhanced human-to-human transmissibility of the virus.

Read the Meeting Report

Read the Summary

For further information :   - CR20     - Seqirus    - Wellcome Trust    - Boehringer Ingelheim    - hVIVO    - HIC-Vac

The speakers

• Prof. Bruno Lina, professor of Virology, University Claude Bernard Lyon and Director of the research laboratory VirPat   -   Slides - Replay
• Prof. Arnaud Fontanet, Director of the Department of Global Health, Head of the Emerging Diseases Epidemiology Unit, Institut Pasteur   -   Slides - Replay
• Prof. Arnaud Marchant, Director of the Institute for Medical Immunology, Université Libre de Bruxelles   -   Slides - Replay
• Dr. Melanie Saville, Head of Vaccine R&D, CEPI Vaccines   -   Slides - Replay

The complete set of speakers slides are available Here

Agenda

14:00    Welcome & Introduction
             Dr. Joris Vandeputte, President, IABS

14:05    Epidemiology: the latest data on the pandemic
             Prof. Arnaud Fontanet

14:20    What do we now know about the SARS-CoV-2 virus?
             Prof. Bruno Lina

14:35    The disease from the viewpoint of an immunologist
             Prof. Arnaud Marchant

14:50     Vaccine development - where are we now?
               Dr. Melanie Saville

15:05    Q&A
             Dr. Joris Vandeputte

16:00    End of webinar

   IABS offers Open Access to its SARS-CoV-2 series of webinars